Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

682

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Influenza Immunization
Interventions
BIOLOGICAL

Quadrivalent Influenza mRNA Vaccine MRT5410

Pharmaceutical form: Liquid frozen solution for injection in a vial Route of administration: Intramuscular

BIOLOGICAL

Quadrivalent Recombinant Influenza vaccine RIV4

Pharmaceutical form: Liquid suspension for injection in prefilled syringe Route of administration: Intramuscular

BIOLOGICAL

Quadrivalent Inactivated Influenza Standard Dose QIV-SD

Pharmaceutical form: Liquid suspension for injection in prefilled syringe Route of administration: Intramuscular

BIOLOGICAL

Quadrivalent Inactivated Influenza High Dose QIV-HD

Pharmaceutical form: Liquid suspension for injection in prefilled syringe Route of administration: Intramuscular

Trial Locations (25)

29405

Coastal Carolina Research Center - N Charleston Site Number : 8400007, North Charleston

32607

SIMEDHealth, LLC Site Number : 8400042, Gainesville

33012

Indago Research and Health Center Site Number : 8400002, Hialeah

33024

Research Centers of America Site Number : 8400011, Hollywood

33173

Florida International Research Center Site Number : 8400009, Miami

33409

Palm Beach Research Center Site Number : 8400041, West Palm Beach

37919

AMR Knoxville Site Number : 8400021, Knoxville

40509

AMR Lexington Site Number : 8400035, Lexington

46260

Brengle Family Medicine Site Number : 8400040, Indianapolis

68134

Velocity Clinical Research Site Number : 8400034, Omaha

68701

Meridian Clinical Research Site Number : 8400017, Norfolk

77338

DM Clinical Research Site Number : 8400046, Humble

77375

Martin Diagnostic Clinic Site Number : 8400058, Tomball

77478

DM Clinical Research - Sugar Land Site Number : 8400045, Sugar Land

78229

Clinical Trials of Texas, Inc. - PPDS Site Number : 8400043, San Antonio

78704

Elligo Health Research, Inc. Site Number : 8400037, Austin

78745

Tekton Research, Inc Site Number : 8400051, Austin

83642

Velocity Clinical Research Site Number : 8400024, Meridian

89106

WR-CRCN, LLC Site Number : 8400060, Las Vegas

90255

Joint Clinical Trials Huntington Park Site Number : 8400032, Huntington Park

90806

Long Beach Clinical Trials Site Number : 8400056, Long Beach

91606

Velocity Clinical Research, North Hollywood Site Number : 8400063, North Hollywood

92123-1881

California Research Foundation Site Number : 8400001, San Diego

00694

Investigational Site Number : 6300002, Barrio Sabana

00909

Investigational Site Number : 6300001, San Juan

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY